World Menopause Day: PharmaLinea launches advanced capsule solution ahead of CPHI 2022
18 Oct 2022 --- PharmaLinea is launching Your Meno Ease Capsules on World Menopause Day to improve the quality of women’s social, work and personal lives when facing some of the more distressing symptoms of menopause. According to the company, women may spend up to 40% of their lifetime in post-menopause due to increased life expectancy, making the need to address menopause-associated symptoms more essential.
“The product is an advanced version of a recognized classic,” Matevž Ambrožič, marketing and PR director at PharmaLinea, tells NutritionInsight. “Classic in the sense of being based on recognized ingredients such as soy isoflavones, targeting key menopause symptom relief and advanced in using branded and clinically studied sources of the main ingredients to address a wider array of health benefits.”
“We have several projects in the pipeline, both in developing new products and performing clinical trials on our existing products,” Ambrožič says. “We are focusing most on further developing our line of children’s supplements, as well as our line of products addressing various forms of pain.”
Decreasing the effects
According to the company, 33% of perimenopausal women take supplements to address health concerns and relieve menopausal symptoms. DSM, PharmaCare and Pharmavite all have exclusive supplements to address menopause’s symptoms.
PharmaLinea’s offering comes in a one-capsule dose containing 75 mg of Qratol and 40 mg of Qsoy. It also contains 1.6 mg of vitamin B6. Qsol is a soy ingredient that has been shown to alleviate menopause symptoms, while Qratol is a reservatol ingredient that has been shown to have numerous health effects.
PharmaLinea’s solution is delivered in a one-capsule dose containing Qsol, a soy ingredient shown to alleviate menopause symptoms.
“There are clinically supported benefits in cognition, mood, risk of cardiovascular diseases, bone density and pain perception,” Ambrožič elaborates. “This adds multiple positioning options for clients that will launch the product under their brand.”
Thinking outside the box
PharmaLinea states that the new product is a modern application of traditional medicines. According to the company, women’s health has a long history of being addressed through conventional herbal supplements. It also admits that science has had a hard time confirming the safety and efficacy of such products.
PharmaLinea says the difference with its product is that it utilizes heavily studied and recognized ingredients with scientific backing and not merely a cornucopia of vitamins and minerals that may or may not have an effect.
“Menopause supplements are on the rise,” says Ambrožič. “It used to be mainly basic vitamins and minerals, non-specifically formulated, using commodity sources, focusing only on symptom relief and not perceiving the wider implications of menopause.”
“A new, second generation of products is coming in with branded clinically studied ingredients and looking at wider health systems.”
Maja Orešnik, science and research director at PharmaLinea, agrees with Ambrožič, noting that though there are many ingredients on the market that claim to treat menopausal symptoms and optimize women’s health, it is rare that the combinations of ingredients or the ingredients used will improve symptoms.
“Our new formulation is a combination of a recognized natural ingredient with proven benefits in menopausal health and an active molecule originating from an innovative yeast fermentation process,” she stresses.
CPHI online exhibition
At the upcoming CPHI trade show in Frankfurt, Germany, the company will focus on creating new business opportunities and meeting potential partners, noting that the online exhibitors can utilize a matchmaking platform which aids in meeting companies with shared visions and goals.
“The pandemic has had many effects on the way we do business, and the surge of matchmaking platforms has been one of the more positive ones,” Ambrožič explains. “Exhibiting with a stand at trade shows, of course, has its many advantages, but it is random, and you are more dependent on the right person walking by solely by chance.”
“When exhibiting online, we circumvent the randomness, prepare for meetings that we arrange and have much more efficient discussions.”
Ambrožič further explains that the company aims to connect with pharma companies that either have food supplement divisions and brands or that may be looking to enter into the space, noting that such companies are often looking for science-backed products that address more health issues.
“Hence, we will be promoting our launches in iron deficiency, and urinary tract infections, as well as our new line of prebiotic supplements,” Ambrožič underscores. “While the latter may gravitate a bit more toward lifestyle conditions and products, recently pharma giants like Sanofi have been launching prebiotics, so there seems to be an opportunity in the pharma space.”
“Additionally, two of our existing lines addressing sleep and back pain are recently in high demand, and we expect this to be no different at CPHI.”
By William Bradford Nichols
